New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from ...

Study Finds No Link Between Migraine and Parkinson's Disease Aug. 21, 2024 — Contrary to previous research, a new study of female participants finds no link between migraine and the risk of ...

Researchers at Karolinska Institutet have identified a mechanism responsible for a serious psychiatric complication caused by ...

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

New research suggests that a novel drug molecule could lead to treatments preventing Parkinson’s disease in younger patients.

The NHS has committed to ending deadly delays in giving “time critical” medication to Parkinson’s patients in hospital, The ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

The Fox News Health Newsletter brings you trending and important stories about health warnings, drug shortages, mental health ...